Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid

Authors

Richard E. Ostlund Jr., Washington University School of Medicine in St. Louis
David Gibson, Washington University School of Medicine in St. Louis
et al

Journal

Alzheimer's & Dementia

Publication Date

2016

Volume

12

Issue

5

Inclusive Pages

517-526

Document Type

Open Access Publication

DOI

10.1016/j.jalz.2015.09.009

Rights and Permissions

Bittner T, Zetterberg H, Teunissen CE, et al (2016) Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid. Alzheimer's & Dementia, 12(5):517-526. https://doi.org/10.1016/j.jalz.2015.09.009 Copyright 2015 The Authors. Published by Elsevier Inc. on behalf of Alzheimer’s Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Ostlund, Richard E. Jr.; Gibson, David; and et al, "Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid." Alzheimer's & Dementia. 12, 5. 517-526. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/6310